Advanced search
Publication Cover
Gynecological Endocrinology Volume 38, 2022 - Issue 9
Submit an article Journal homepage
147
Views
0
CrossRef citations to date
0
Altmetric
Polycystic ovary syndrome

Bone morphogenetic protein-9 maybe an important factor which improves insulin resistance in PCOS

Xiaoying Yuana Department of Endocrinology and metabolism, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaORCID Iconhttps://orcid.org/0000-0002-6262-2804View further author information
ORCID Icon,
Qi Huangb Department of Nuclear Medicine, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
,
Jing Lia Department of Endocrinology and metabolism, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
,
Qu Yaoa Department of Endocrinology and metabolism, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
,
Han Zhanga Department of Endocrinology and metabolism, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
,
Qian Wanga Department of Endocrinology and metabolism, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
,
Lin Zhanga Department of Endocrinology and metabolism, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
,
Ying Zhanga Department of Endocrinology and metabolism, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaView further author information
,
Gangyi Yangc Department of Endocrinology, The Second Affiliated Hospital, Chongqing Medical University, Chongqing, ChinaCorrespondence[email protected] [email protected]
View further author information
,
Ling Lid Key Laboratory of Diagnostic Medicine (Ministry of Education), and Department of Clinical Biochemistry, College of Laboratory Medicine, Chongqing Medical University, Chongqing, ChinaView further author information
&
Xin Liaoa Department of Endocrinology and metabolism, Affiliated Hospital of Zunyi Medical University, Zunyi, ChinaCorrespondence[email protected] [email protected]
View further author information
 show all
Pages 781-789 | Received 10 Feb 2022, Accepted 31 Jul 2022, Published online: 11 Aug 2022

References

  • Agrawal A, Mahey R, Kachhawa G, et al. Comparison of metformin plus myoinositol vs metformin alone in PCOS women undergoing ovulation induction cycles: randomized controlled trial. Gynecol Endocrinol. 2019;35(6):511–514.
  • Andrae F, Abbott D, Stridsklev S, et al. Sustained maternal hyperandrogenism during PCOS pregnancy reduced by metformin in non-obese women carrying a male fetus. J Clin Endocrinol Metab. 2020;105(12):3762–3770.
  • Patel S. Polycystic ovary syndrome (PCOS), an inflammatory, systemic, lifestyle endocrinopathy. J Steroid Biochem Mol Biol. 2018;182:27–36.
  • Lee H, OH JY, Sung YA, et al. Is insulin resistance an intrinsic defect in Asian polycystic ovary syndrome? Yonsei Med J. 2013;54(3):609–614.
  • Li MF, Zhou XM, Li XL. The effect of berberine on polycystic ovary syndrome patients with insulin resistance (PCOS-IR): a meta-analysis and systematic review. Evid Based Complement Alternat Med. 2018;2018:2532935.
  • Fruzzetti F, Perini D, Russo M, et al. Comparison of two insulin sensitizers, metformin and myo-inositol, in women with polycystic ovary syndrome (PCOS). Gynecol Endocrinol. 2017;33(1):39–42.
  • Shah P, Keppler L, Rutkowski J. Bone morphogenic protein:an elixir for bone afting – a review. J Oral Implantol. 2012;38(6):767–778.
  • Fang L, Jia Q, Liu B, et al. BMP-9 downregulates StAR expression and progesterone production by activating both SMAD1/5/8 and SMAD2/3 signaling pathways in human granulosa-lutein cells obtained from gonadotropins induced ovarian cycles. Cell Signal. 2021;86:110089.
  • Luo Y, Li L, Xu X, et al. Decreased circulating BMP-9 levels in patients with type 2 diabetes is a signature of insulin resistance. Clin Sci (Lond). 2017;131(3):239–246.
  • Zhang L, Fang X, Li L, et al. The association between circulating irisin levels and different phenotypes of polycystic ovary syndrome[J]. J Endocrinol Invest. 2018;41(12):1401–1407.
  • Barrea L, Arnone A, Annunziata G, et al. Adherence to the Mediterranean diet, dietary patterns and body composition in women with polycystic ovary syndrome (PCOS. Nutrients. 2019;11(10):2278. )
  • Song S, Tan Y. Expression of FKBP52 in the ovaries of PCOS rats. Int J Mol Med. 2019;43(2):868–878.
  • Escobar-Morreale Héctor F. Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment. Nat Rev Endocrinol. 2018;14(5):270–284.
  • Greenwood EA, Pasch LA, Shinkai K, et al. Putative role for insulin resistance in depression risk in polycystic ovary syndrome. Fertil Steril. 2015;104(3):707–714.
  • Bannigida DM, Nayak BS, Vijayaraghavan R. Insulin resistance and oxidative marker in women with PCOS. Arch Physiol Biochem. 2020;126(2):183–186.
  • Shorakae S, Ranasinha S, Abell S, et al. Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS. Clin Endocrinol (Oxf). 2018;89(5):628–633.
  • Francis d Z, Abel L-B, Lourdes I. Central obesity, faster maturation, and ‘PCOS’ in girls. Trends Endocrinol. Metab. 2018;29(12):815–818.
  • Roe AH, Prochaska E, Smith M, et al. Using the androgen excess-PCOS society criteria to diagnose polycystic ovary syndrome and the risk of metabolic syndrome in adolescents. J Pediatr. 2013;162(5):937–941.
  • Gaitantzi H, Karch J, Germann L, et al. BMP-9 modulates the hepatic responses to LPS. Cells. 2020;9(3):617.
  • Kim M, Choe S. BMPs and their clinical potentials. BMB Rep. 2011;44(10):619–634.
  • Xu X, Li X, Yang G, et al. Circulating bone morphogenetic protein-9 in relation to metabolic syndrome and insulin resistance. Sci Rep. 2017;7(1):17529.
  • Huang H, Wang W, Yang G, et al. Circulating bone morphogenetic protein-9 levels are associated with hypertension and insulin resistance in humans. J Am Soc Hypertens. 2018;12(5):372–380.
  • Hosoya T, Otsuka F, Nakamura E, et al. Regulatory role of BMP-9 in steroidogenesis by rat ovarian granulosa cells. J Steroid Biochem Mol Biol. 2015;147(5):85–91.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.